Clinical Trial Update: An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing two standard-of-care cardiac monitoring schedules for patients receiving trastuzumab for early-stage breast cancer has completed, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2025-07-14